Novartis has signed an agreement to divest its 'front of eye' ophthalmology assets to Bausch + Lomb, a global eye health company. The transaction is valued at up to $2.5...
28.07.2017
- Clariant may be willing to divest 25% of its portfolio, including its Pigments and Masterbatches businesses, following the planned $20 billion merger with US family-owned chemical...
04.05.2017
- China has become the second major trading bloc to conditionally approve the proposed $130 merger of US chemical giants Dow and DuPont. The green light from the Ministry of Commerce...
